ADOLOR CORP 4
4 · ADOLOR CORP · Filed May 25, 2010
Insider Transaction Report
Form 4
ADOLOR CORPADLR
Salinas Eliseo Oreste
SVP R&D & CMO
Transactions
- Tax Payment
Common Stock
2010-05-24$1.57/sh−3,825$6,005→ 88,675 total - Award
Common Stock
2010-05-24+12,500→ 92,500 total
Footnotes (2)
- [F1]Represents vesting of performance-based deferred share award upon filing under Dr. Salinas direction of an investigational new drug application ("IND") with the FDA, pursuant to the terms of Dr. Salinas' employment agreement with the Company.
- [F2]Represents shares withheld to cover taxes associated with the deferred share vesting dated 5/24/2010